Sage Journals: Discover world-class research

Retricted access

Research article

First published 2024-02

Establishment of Anti-Dog Programmed Cell Death Ligand 1 Monoclonal Antibodies for Immunohistochemistry

Tsunenori Ouchida, Hiroyuki Suzuki, Tomohiro Tanaka [...]

Monoclonal Antibodies in Immunodiagnosis & Immunotherapy

Open access

Case report

First published 2024-12

Tracheobronchial chondritis as an immune-related adverse event occurring during the administration of nivolumab for recurrent hypopharyngeal squamous cell carcinoma

Miwako Someya, Takahito Kondo, Akira Okimura [...]

Ear,Nose & Throat Journal

Retricted access

Brief report

First published 2023-10

Capillary leak syndrome with immune checkpoint inhibitors and anti-cancer targeted therapy agents: Not that common

Tanazul Pariswala, Qiyu Wang, Vipulbhai Sakhiya [...]

Journal of Onco-Nephrology

Open access

Case report

First published 2025-4

Laryngeal Cancer With Lung Metastases Showing Long-Term Complete Response and Delayed Immune-Related Adverse Event After Nivolumab Discontinuation

Takahito Kondo, Munehide Nakatsugawa, Mitsuru Okubo [...]

Ear,Nose & Throat Journal

Free access

Review article

First published 2017-5

Targeting the programmed cell death 1 pathway in Hodgkin lymphoma: the place of nivolumab

Nathan D. Gay, Craig Y. Okada, Andy I. Chen [...]

Therapeutic Advances in Hematology

Free access

Research article

First published 2022-11

Brain-derived programmed death-ligand 1 mediates immunosuppression post intracerebral hemorrhage

Nuo Cheng, Hong Wang, Ming Zou [...]

Journal of Cerebral Blood Flow & Metabolism

Retricted access

Research article

First published 1989-9

Growth Control of Normal and Malignant Lymphocytes

Peter H. Krammer

Interdisciplinary Science Reviews

Free access

Review article

First published 2018-4

Pembrolizumab and its role in relapsed/refractory classical Hodgkin’s lymphoma: evidence to date and clinical utility

Polina Shindiapina, Lapo Alinari

Therapeutic Advances in Hematology

Open access

Review article

First published 2020

Current status of treatment with immune checkpoint inhibitors for gastrointestinal,hepatobiliary,and pancreatic cancers

Yuji Eso, Hiroshi Seno

Therapeutic Advances in Gastroenterology

Open access

Review article

First published 2019

Current Clinical Progress of PD-1/PD-L1 Immunotherapy and Potential Combination Treatment in Non–Small Cell Lung Cancer

Jia-Xin Li, Ju-Min Huang, Ze-Bo Jiang [...]

Integrative Cancer Therapies

Search results